Compare Nucleus Soft. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -1.13% of over the last 5 years
The company has declared Negative results for the last 4 consecutive quarters
With ROE of 14.9, it has a Very Expensive valuation with a 2.1 Price to Book Value
Falling Participation by Institutional Investors
Below par performance in long term as well as near term
Stock DNA
Software Products
INR 1,816 Cr (Small Cap)
14.00
21
1.73%
-0.45
14.89%
2.13
Total Returns (Price + Dividend) 
Latest dividend: 12.460322708636424 per share ex-dividend date: Jul-10-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Nucleus Software Exports Ltd Falls to 52-Week Low of Rs 681.5 as Sell-Off Deepens
A sharp decline over the past two sessions has dragged Nucleus Software Exports Ltd to a fresh 52-week low of Rs 681.5 on 31 Jul 2026, marking a 36.36% drop over the last year and signalling sustained pressure on the stock despite a broadly stable market backdrop.
Read full news article
Nucleus Software Q1 FY27: Profitability Plunges as Employee Costs Surge
Nucleus Software Exports Ltd., a global provider of enterprise lending and transaction banking solutions, reported a sharp decline in profitability for Q1 FY27, with net profit plummeting 30.91% quarter-on-quarter to ₹23.87 crores from ₹34.55 crores in Q4 FY26. Year-on-year comparisons paint an even grimmer picture, with profits down 32.19% from ₹35.20 crores in Q1 FY26. The small-cap software products company, commanding a market capitalisation of ₹1,983 crores, has seen its shares tumble 27.35% over the past year, significantly underperforming both the Sensex and its sector peers.
Read full news article
Nucleus Software Exports Ltd Sees Mixed Technical Signals Amid Bearish Momentum
Nucleus Software Exports Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest intraday price gain of 2.05%, the stock’s broader technical landscape suggests caution for investors amid mixed signals from MACD, RSI, and moving averages.
Read full news article Announcements 
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
28-Jul-2026 | Source : BSEPlease find enclosed herewith the Disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015
Shareholder Meeting / Postal Ballot-Scrutinizers Report
28-Jul-2026 | Source : BSEPleased find Enclosed herewith the Scrutinizers Report along with Voting Results of Annual General Meeting held on July 27 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
27-Jul-2026 | Source : BSEProceedings of the 37th AGM of the Company held on July 27 2026
Corporate Actions 
No Upcoming Board Meetings
Nucleus Software Exports Ltd has declared 125% dividend, ex-date: 10 Jul 26
No Splits history available
Nucleus Software Exports Ltd has announced 1:1 bonus issue, ex-date: 03 Aug 07
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (1.07%)
Held by 60 FIIs (3.32%)
Karmayogi Holdings Private Limited (33.59%)
Whiteoak Capital Flexi Cap Fund (1.07%)
18.32%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -6.38% vs 2.15% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is -30.91% vs 66.91% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.46% vs -3.51% in Sep 2024
Growth in half year ended Sep 2025 is -2.80% vs -35.55% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 7.95% vs -2.09% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -16.33% vs -29.56% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 5.26% vs 0.70% in Mar 2025
YoY Growth in year ended Mar 2026 is -28.38% vs -14.93% in Mar 2025






